NCT05709626RecruitingPhase 4
PRasugrEl Monotherapy Following prImary percUtaneous Coronary Intervention for ST-elevation Myocardial Infarction
Source: ClinicalTrials.gov · Last updated 1 Mar 2023 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
The aim of this study is to evaluate the safety of prasugrel monotherapy without aspirin versus 12-month dual antiplatelet therapy (DAPT) in patients with STEMI using platinum-chrome everolimus-eluting stent (PtCr-EES: SYNERGYTM).
- Status (registry)
- Recruiting
- Phase (registry)
- Phase 4
- Study type
- Interventional
- Enrollment
- 2258 (estimated)
- First submitted
- 19 Jan 2023
- Start date
- 28 Feb 2023
- Primary completion date
- 4 Jan 2025
- Lead sponsor
- Kindai University
- Diseases
- Coronary artery disease
- NCT number
- NCT05709626
What you commit to
- Study type: Interventional · Phase 4
- Planned participants: 2258
- From 28 Feb 2023 to the primary completion date, 4 Jan 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Age
- Patients under 18 years old
Other
- Patients taking anticoagulants
- Patients with less than 1 year prognosis
- Patients participating in other intervention studies
Who the study is looking for
- Patients scheduled for primary PCI with everolimus-eluting stent (PtCr-EES, SYNERGYTM)
- STEMI patients
- Patients who can continue dual antiplatelet therapy with aspirin and a P2Y12 inhibitor for 12 months
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Kindai University Faculty of Medicine Coordinator of this site? Confirm its status | Sayama | Japan | Recruiting |
Related publications
- Aspirin Omission at the Time of Primary Percutaneous Coronary Intervention in STEMI.N Engl J Med · 2026 · PMID 42670955
- Prasugrel monotherapy versus 12-month dual antiplatelet therapy in STEMI patients undergoing intravascular imaging-guided PCI: Study design and rationale of the randomized PREMIUM trial.Cardiovasc Revasc Med · 2026 · PMID 41436299
This page is information, not medical advice. Discuss any trial with your doctor.